GQ1011
Undisclosed (FGFR3-targeting)
PreclinicalCollaboration (Aimed Bio)
Key Facts
Indication
Undisclosed (FGFR3-targeting)
Phase
Preclinical
Status
Collaboration (Aimed Bio)
Company
About GeneQuantum
A global leader in ADC technology, developing next-generation bioconjugate therapeutics with proprietary enzymatic conjugation platforms.
View full company profile